Isomorphic Labs Watch posted an update
Isomorphic Labs is linked to a reported $5bn funding round at a rumoured $50bn valuation, according to BigGo Finance’s account of discussions at London Life Sciences Week. The figures are not presented as a confirmed deal.
Why it mattersThe reported valuation drew sharply different reactions from traditional biotech and health-tech investors. That divide captures the bet: investors are being asked to price AI drug discovery on the possibility of major pharmaceutical scale, before the clinical results can settle the argument. BigGo’s account attributes the discussion to conference attendees, rather than naming a confirmed investor or citing a completed transaction.
Discuss: Is this a bold bet on AI-led drug discovery, or a valuation that needs more evidence before it makes sense?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.